Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
Amélie I S Sobczak1, Claudia A Blindauer2, Alan J Stewart3
1School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.
Type 2 diabetes mellitus (T2DM) is linked to higher free fatty acid (FFA) levels, increasing cardiovascular risk. Understanding specific FFA changes in T2DM is crucial for managing metabolic and cardiovascular complications.
Area of Science:
- Biochemistry
- Endocrinology
- Metabolic Disorders
Background:
- Type 2 diabetes mellitus (T2DM) is associated with elevated plasma free fatty acid (FFA) concentrations.
- Increased FFAs correlate with a higher risk of cardiovascular disease in T2DM patients.
- The precise mechanisms driving FFA profile alterations in T2DM remain incompletely understood, with dietary fats and lipid metabolism changes implicated.
Purpose of the Study:
- To review alterations in specific free fatty acid (FFA) concentrations in individuals with Type 2 diabetes mellitus (T2DM).
- To explore the physiological and pathological implications of altered FFA profiles in T2DM.
- To consider the impact of lipid-regulating drugs (fibrates and statins) on plasma FFA concentrations in T2DM.
Main Methods:
- Review of existing literature on FFA profiles in T2DM.
- Analysis of the physiological roles of different FFAs.
- Examination of the effects of T2DM and related medications on FFA metabolism.
Main Results:
- Specific FFAs exhibit altered concentrations in T2DM plasma.
- These alterations can influence lipolysis, lipogenesis, inflammation, and endocrine signaling.
- Changes in FFA profiles may contribute to insulin resistance and coagulatory defects.
- Lipid-regulating drugs may impact plasma FFA concentrations, contributing to their therapeutic benefits.
Conclusions:
- Altered plasma FFA profiles are a significant feature of T2DM with broad physiological consequences.
- Understanding these changes is vital for elucidating T2DM pathophysiology and developing targeted therapies.
- Further research into FFA dynamics and drug interactions in T2DM is warranted.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
03:17Static Strength Training Method for Type 2 Diabetic Mice
10:43Preparation, Purification, and Use of Fatty Acid-containing Liposomes
08:41Identification of Fatty Acids in Bacillus cereus
07:44Analysis of Fatty Acid Content and Composition in Microalgae
07:27Optimized Incorporation of Alkynyl Fatty Acid Analogs for the Detection of Fatty Acylated Proteins using Click Chemistry

